We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies. Close

Pharma patent agreements ‘contrary’ to EU competition law

Intellectual Property Magazine

Pharma patent agreements ‘contrary’ to EU competition law

The Court of Justice for the EU (CJEU) has ruled that a settlement agreement between a pharma patent holder and a generic manufacturer not to enter a specific market in return for monetary payments, is contrary to EU competition law.

The rest of this document is only available to i-law.com online subscribers.

If you are already a subscriber, please enter your details below to log in.

Enter your email address to log in as a user on your corporate account.
Remember me on this computer

Not yet an i-law subscriber?


Request a trial Find out more